AIM
MDGL icon

Advantage Investment Management’s Madrigal Pharmaceuticals MDGL Stock Holding History

Advantage Investment Management’s Portfolio MDGL Stock Details MDGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-11
Closed -$1K – 1032
2017
Q4 		$1K Buy
+11
New +$628 ﹤0.01% 963
2016
Q3 		– Sell
-43
Closed – – 939
2016
Q2 		$0 Hold
43
– – ﹤0.01% 894
2016
Q1 		$0 Hold
43
– – ﹤0.01% 891
2015
Q4 		$1K Hold
43
– – ﹤0.01% 825
2015
Q3 		$3K Hold
43
– – ﹤0.01% 718
2015
Q2 		$3K Hold
43
– – ﹤0.01% 742
2015
Q1 		$3K Hold
43
– – ﹤0.01% 745
2014
Q4 		$4K Buy
+43
New +$4.45K ﹤0.01% 642

Other funds holding MDGL

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return